A Randomized Controlled Tolerability Study to Evaluate Reformulated Benzoyl Peroxide Face Washes for Acne Vulgaris
Santos-Caetano, J.ão.P..; Cargill, M.R..
Journal of Drugs in Dermatology Jdd 18(4): 350-356
2019
ISSN/ISBN: 1545-9616 PMID: 31012563 Document Number: 17764
Introduction: This randomized, evaluator-blind, single-center, parallel-group study sought to evaluate the tolerability of two reformulated face washes containing benzoyl peroxide (BPO) in adults with mild to moderate acne vulgaris.
Document emailed within 1 workday
Related Documents
Babaeinejad, S.H.; Fouladi, R.F. 2013: The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial Journal of Drugs in Dermatology: Jdd 12(7): 790-794Babaeinejad, S.H.; Fouladi, R.F. 2013: The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial Journal of Drugs in Dermatology: Jdd 12(9): 1033-1038
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Bowman, S.; Gold, M.; Nasir, A.; Vamvakias, G. 2005: Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology: Jdd 4(5): 611-618
Gold, M.H. 2006: A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 5(5): 442-445
Jain, V.K.; Chopra, K.L.; Dayal, S. 1998: Comparative evaluation of topical benzoyl peroxide, metronidazole and benzoyl peroxide - clindamycin combination in treatment of acne vulgaris Indian Journal of Dermatology Venereology and Leprology 64(2): 71-74
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Guerra-Tapia, A. 2012: Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study Journal of Drugs in Dermatology: Jdd 11(6): 714-722
Wokalek, H. 1989: Open, controlled multicenter trial of 2 benzoyl peroxide preparations in the treatment of acne vulgaris Zeitschrift für Hautkrankheiten 64(2): 140-144
Del Rosso, J.Q. 2007: Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris Journal of Drugs in Dermatology: Jdd 6(6): 616-622
Kircik, L.H.; Gwazdauskas, J.; Butners, V.; Eastern, J.; Green, L.J. 2013: Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne Journal of Drugs in Dermatology: Jdd 12(3): 259-264
Tanghetti, E.; Abramovits, W.; Solomon, B.; Loven, K.; Shalita, A. 2006: Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial Journal of Drugs in Dermatology: Jdd 5(3): 256-261
Liddell, K. 1974: Benzoyl peroxide gel in the treatment of acne vulgaris British Journal of Clinical Practice 28(11): 379-382
Thiboutot, D.; Gold, M.H.; Jarratt, M.T.; Kang, S.; Kaplan, D.L.; Millikan, L.; Wolfe, J.; Loesche, C.; Baker, M. 2001: Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris Cutis 68(4 Suppl): 10-19
Kircik, L.; Green, L.; Thiboutot, D.; Tanghetti, E.; Wilson, D.; Dhawan, S.; Parr, L. 2009: Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study Journal of Drugs in Dermatology: Jdd 8(9): 812-818
Feldman, S.R.; Werner, C.P.; Alió Saenz, A.B. 2013: The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies Journal of Drugs in Dermatology: Jdd 12(4): 438-446
Tschen, E.; Jones, T. 2002: A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin Journal of Drugs in Dermatology: Jdd 1(2): 153-157
Gloor, M.; Hummel, A.; Friederich, H.C. 1975: Experimental studies on the benzoyl-peroxide therapy of acne vulgaris Zeitschrift für Hautkrankheiten 50(15): 657-663
Fakhouri, T.; Yentzer, B.A.; Feldman, S.R. 2009: Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability Journal of Drugs in Dermatology: Jdd 8(7): 657-661